From July 1, US Medicare seniors get landmark obesity drug coverage — many don't know yet

Starting July 1, US seniors enrolled in Medicare will gain landmark coverage for obesity drugs, including GLP-1 medications. Many may be unaware of the change, as neither the government nor drug makers Eli Lilly and Novo Nordisk have run major advertising campaigns to inform them. Experts warn that without proper outreach, many eligible seniors will miss out on the new benefit.

More on this topic

🏥 Health Medicare to cover obesity drugs for the first time, including Ozempic CNBC · 25d ago 🏥 Health Who benefits from classifying obesity as a disease? Pharma firms lead the push STAT News · 16d ago 🏥 Health Trump's GLP-1 drug deal with Lilly and Novo Nordisk has a hidden loophole — prices didn't fall STAT News · 25d ago

More on this topic

🏥 Health Medicare to cover obesity drugs for the first time, including Ozempic CNBC · 25d ago 🏥 Health Who benefits from classifying obesity as a disease? Pharma firms lead the push STAT News · 16d ago 🏥 Health Trump's GLP-1 drug deal with Lilly and Novo Nordisk has a hidden loophole — prices didn't fall STAT News · 25d ago